| 标题 |
Efficacy and safety of camrelizumab plus apatinib in patients with advanced esophageal squamous cell carcinoma previously treated with immune checkpoint inhibitors (CAP 02 Re-challenge): A single-arm, phase II study |
| 网址 | |
| DOI | |
| 其它 |
期刊:European Journal of Cancer 作者:Xiangrui Meng; Junsheng Wang; Jin Xia; Tao Wu; Zhiquan Luo; et al 出版日期:2024-09-12 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人或该文件上传人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)